<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35969597</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>8</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support.</ArticleTitle><Pagination><StartPage>e0271978</StartPage><MedlinePgn>e0271978</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0271978</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0271978</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Individuals with Long Covid represent a new and growing patient population. In England, fewer than 90 Long Covid clinics deliver assessment and treatment informed by NICE guidelines. However, a paucity of clinical trials or longitudinal cohort studies means that the epidemiology, clinical trajectory, healthcare utilisation and effectiveness of current Long Covid care are poorly documented, and that neither evidence-based treatments nor rehabilitation strategies exist. In addition, and in part due to pre-pandemic health inequalities, access to referral and care varies, and patient experience of the Long Covid care pathways can be poor. In a mixed methods study, we therefore aim to: (1) describe the usual healthcare, outcomes and resource utilisation of individuals with Long Covid; (2) assess the extent of inequalities in access to Long Covid care, and specifically to understand Long Covid patients' experiences of stigma and discrimination.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">A mixed methods study will address our aims. Qualitative data collection from patients and health professionals will be achieved through surveys, interviews and focus group discussions, to understand their experience and document the function of clinics. A patient cohort study will provide an understanding of outcomes and costs of care. Accessible data will be further analysed to understand the nature of Long Covid, and the care received.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Ethical approval was obtained from South Central-Berkshire Research Ethics Committee (reference 303958). The dissemination plan will be decided by the patient and public involvement and engagement (PPIE) group members and study Co-Is, but will target 1) policy makers, and those responsible for commissioning and delivering Long Covid services, 2) patients and the public, and 3) academics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramasawmy</LastName><ForeName>Mel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4864-8565</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clutterbuck</LastName><ForeName>Donna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pantelic</LastName><ForeName>Marija</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lip</LastName><ForeName>Gregory Y H</ForeName><Initials>GYH</Initials><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp; Chest Hospital, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Feltz-Cornelis</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6925-8956</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences, HYMS, University of York, York, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wootton</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Infection Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Nefyn H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Primary Care and Mental Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Hugh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Centre for Human Health and Performance, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallinson Cookson</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>PPIE Representative, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attree</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>PPIE Representative, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabbay</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Primary Care and Mental Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heightman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwan</LastName><ForeName>Nisreen A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Wessex, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorgelly</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Population Health and Department of Economics, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>STIMULATE-ICP Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COV-LT2-0043</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019091" MajorTopicYN="N">Critical Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019033" MajorTopicYN="Y">Delivery of Health Care, Integrated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>HM has advised Axcella Health Inc on trial design in Long Covid; has consulted for AstraZeneca on monoclonal antibody use in acute covid prevention and treatment; and Millfield Medical in the development of a new CPAP machine. CvdF-C has no competing interests to declare. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim and Daiichi-Sankyo. No fees are received personally.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>15</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35969597</ArticleId><ArticleId IdType="pmc">PMC9377596</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0271978</ArticleId><ArticleId IdType="pii">PONE-D-22-13818</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization, &#x201c;A clinical case definition of post COVID-19 condition by a Delphi consensus,&#x201d; Oct. 2021. Accessed: Mar. 16, 2022. [Online]. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
doi: 10.1016/S1473-3099(21)00703-9
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of National Statistics, &#x201c;Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK&#x2014;Office for National Statistics,&#x201d; Sep. 16, 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021 (accessed Mar. 15, 2022).</Citation></Reference><Reference><Citation>Office of National Statistics, &#x201c;Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK&#x2014;Office for National Statistics,&#x201d; Mar. 03, 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3march2022 (accessed Mar. 15, 2022).</Citation></Reference><Reference><Citation>Al-Aly Z., Xie Y., and Bowe B., &#x201c;High-dimensional characterization of post-acute sequelae of COVID-19,&#x201d; Nature 2021 594:7862, vol. 594, no. 7862, pp. 259&#x2013;264, Apr. 2021, doi: 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S. et al., &#x201c;&#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19,&#x201d; Thorax, vol. 76, no. 4, pp. 396&#x2013;398, Apr. 2021, doi: 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D. et al., &#x201c;Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study,&#x201d; PLoS ONE, vol. 16, no. 7, p. e0254523, Jul. 2021, doi: 10.1371/journal.pone.0254523</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M. et al., &#x201c;Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals,&#x201d; BMJ Open Respiratory Research, vol. 8, no. 1, p. e001041, Nov. 2021, doi: 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C., Luteijn M., Letton W., Robertson J., and McDonald S., &#x201c;A model framework for projecting the prevalence and impact of Long-COVID in the UK,&#x201d; PLoS ONE, vol. 16, no. 12, Dec. 2021, doi: 10.1371/JOURNAL.PONE.0260843</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0260843</ArticleId><ArticleId IdType="pmc">PMC8639065</ArticleId><ArticleId IdType="pubmed">34855874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N. et al., &#x201c;Characteristics and impact of Long Covid: Findings from an online survey,&#x201d; PLoS ONE, vol. 17, no. 3, p. e0264331, Mar. 2022, doi: 10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M. et al., &#x201c;Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study,&#x201d; The Lancet Regional Health&#x2014;Europe, vol. 6, p. 100122, Jul. 2021, doi: 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., and Husain L., &#x201c;Management of post-acute covid-19 in primary care,&#x201d; British Medical Journal, vol. 370, Aug. 2020, doi: 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x201c;NICE, SIGN and RCGP set out further details about the UK guideline on management of the long-term effects of COVID-19 | News and features | News | NICE.&#x201d; https://www.nice.org.uk/news/article/nice-sign-and-rcgp-set-out-further-details-about-the-uk-guideline-on-management-of-the-long-term-effects-of-covid-19 (accessed Mar. 15, 2022).</Citation></Reference><Reference><Citation>NHS England, &#x201c;National Guidance for post-COVID syndrome assessment clinics. Version 2.,&#x201d; no. April, pp. 1&#x2013;44, 2021, [Online]. Available: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/11/C1248-national-guidance-post-covid-syndrome-assessment-clinics-v2.pdf</Citation></Reference><Reference><Citation>Braun V. and Clarke V., &#x201c;Thematic analysis.,&#x201d; in APA handbook of research methods in psychology, Vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological., Washington, DC, US: American Psychological Association, 2012, pp. 57&#x2013;71. doi: 10.1037/13620-004</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/13620-004</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Andon T., Walsh S., Fuld J., and Pari A. A. A., &#x201c;The health system response to long COVID in England&#x2014;at a critical juncture,&#x201d; British Journal of General Practice, vol. 71, no. 712, pp. 485&#x2013;486, Nov. 2021, doi: 10.3399/BJGP21X717401</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP21X717401</ArticleId><ArticleId IdType="pmc">PMC8544151</ArticleId><ArticleId IdType="pubmed">34711556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovett S., &#x201c;&#x2018;Only a fraction&#x2019; of long Covid sufferers able to access NHS support clinics,&#x201d; The Independent, Sep. 12, 2021. Accessed: Mar. 15, 2022. [Online]. Available: https://www.independent.co.uk/news/health/long-covid-nhs-clinic-support-treatment-b1917924.html</Citation></Reference><Reference><Citation>Gallagher P. and Saunders T., &#x201c;Doctors told to stop sending patients to long Covid clinics at large NHS trusts,&#x201d; The i, Jan. 12, 2022. Accessed: Mar. 15, 2022. [Online]. Available: https://inews.co.uk/news/health/doctors-told-stop-sending-patients-long-covid-clinics-large-nhs-trusts-1416130</Citation></Reference><Reference><Citation>van der Feltz-Cornelis C. M. et al., &#x201c;STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study Protocol,&#x201d; medRxiv, vol. 17, p. 2022.04.06.22273514, Apr. 2022, doi: 10.1101/2022.04.06.22273514</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.06.22273514</ArticleId><ArticleId IdType="pmc">PMC9710789</ArticleId><ArticleId IdType="pubmed">36449461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>